This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Sridhar Vaddeboina, Ph.D.
Vice President, Analytical Development at Wave Life Sciences
Speaker

Profile

Dr. Vaddeboina is currently the Senior Vice President overseeing CMC Operations at Wave Life Sciences. He is an experienced oligonucleotide chemist with over 24 years of CMC experience in pharma and biotech. Before joining Wave Life Sciences in 2021, Dr. Vaddeboina served as Vice President of Technology Innovation, Analytical Development, at Avecia. Prior to Avecia, he worked as Senior Director, Drug Development operations and other positions at AMRI (now Curia). Dr. Vaddeboina earned a PhD in chemistry from Osmania University, India, and a graduate certificate in strategic management from Harvard University.

Agenda Sessions

  • Chairperson’s Remarks: Track 1

    10:55am
  • CMC Strategies for the Characterization of Stereopure Platform Chemistry

    11:00am
  • Chairperson’s Remarks: Track 1

    1:40pm